Stockreport

Pyxis Reports Financial Results for the Third Quarter of 2021 and Provides Business Update

Pyxis Oncology, Inc.  (PYXS) 
PDF CAMBRIDGE, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a preclinical oncology company focused on developing next-generation therapeut [Read more]